Form 4: Director David Schmidt Receives Astrana Health Equity Grant

Director David Schmidt was granted 4,525 restricted shares of Astrana Health, Inc. common stock.

Summary

• Director David Schmidt acquired 4,525 shares of common stock in Astrana Health, Inc. (ASTH).
• The shares were granted as restricted stock under the company's 2024 Equity Incentive Plan.
• The grant has a zero-dollar acquisition price.
• The total beneficial ownership for the director following this transaction is 36,019 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard equity incentive grant indicates ongoing retention and incentive alignment for board members.

Negatives

• None identified.

Risks

• Vesting is subject to time-based conditions (June 10, 2027, or the 2027 annual meeting).
• Market volatility could impact the future value of the equity grant.

Future Outlook

The restricted shares are scheduled to vest on June 10, 2027, or upon the date of the 2027 annual meeting of stockholders, whichever occurs first.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the healthcare services sector to ensure long-term alignment between board oversight and shareholder value.

Comparison to Industry Standards

• The grant follows standard industry practices for director compensation in mid-cap healthcare companies.
• The use of a 2024 Equity Incentive Plan is consistent with current corporate governance trends for long-term incentive structures.

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 4,525 restricted shares on June 10, 2027, or the 2027 annual meeting date.

Key Dates

Keywords

Astrana Health, ASTH, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation